Latest Parkman Healthcare Partners LLC Stock Portfolio

Parkman Healthcare Partners LLC Performance:

2025 Q3: 14.65%YTD: 11.35%2024: 8.91%

Performance for 2025 Q3 is 14.65%, and YTD is 11.35%, and 2024 is 8.91%.

About Parkman Healthcare Partners LLC and 13F Hedge Fund Stock Holdings

Parkman Healthcare Partners LLC is a hedge fund based in STAMFORD, CT. On 27-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $591.9 Millions. In it's latest 13F Holdings report, Parkman Healthcare Partners LLC reported an equity portfolio of $958.7 Millions as of 30 Sep, 2025.

The top stock holdings of Parkman Healthcare Partners LLC are BSX, ALNY, PODD. The fund has invested 4.4% of it's portfolio in BOSTON SCIENTIFIC CORP and 4.2% of portfolio in ALNYLAM PHARMACEUTICALS INC.

The fund managers got completely rid off VERONA PHARMA PLC (VRNA), REVVITY INC and GILEAD SCIENCES INC (GILD) stocks. They significantly reduced their stock positions in GENEDX HOLDINGS CORP (SMFR), IQVIA HLDGS INC (IQV) and ELI LILLY & CO (LLY). Parkman Healthcare Partners LLC opened new stock positions in BIOGEN INC (BIIB), ASSEMBLY BIOSCIENCES INC (ASMB) and STOKE THERAPEUTICS INC (STOK). The fund showed a lot of confidence in some stocks as they added substantially to AMICUS THERAPEUTICS INC (FOLD), KALVISTA PHARMACEUTICALS INC (KALV) and UNITED THERAPEUTICS CORP DEL (UTHR).

Parkman Healthcare Partners LLC Annual Return Estimates Vs S&P 500

Our best estimate is that Parkman Healthcare Partners LLC made a return of 14.65% in the last quarter. In trailing 12 months, it's portfolio return was 7.01%.

Performance
S&P 500

New Buys

Ticker	$ Bought
biogen inc	18,233,500
assembly biosciences inc	6,425,110
stoke therapeutics inc	5,875,000
maze therapeutics inc	5,186,000
abivax sa	4,686,220
immunome inc	4,111,740
agios pharmaceuticals inc	4,029,250
spyre therapeutics inc	3,364,620

New stocks bought by Parkman Healthcare Partners LLC

Additions

Ticker	% Inc.
amicus therapeutics inc	177
kalvista pharmaceuticals inc	155
united therapeutics corp del	149
urogen pharma ltd	127
waystar hldg corp	118
inspiremd inc	97.57
apogee therapeutics inc	91.02
mckesson corp	63.49

Additions to existing portfolio by Parkman Healthcare Partners LLC

Reductions

Ticker	% Reduced
genedx holdings corp	-74.14
iqvia hldgs inc	-72.6
eli lilly & co	-69.97
mannkind corp	-65.49
travere therapeutics inc	-58.92
tenet healthcare corp	-55.99
cooper cos inc	-54.21
ultragenyx pharmaceutical in	-53.62

Parkman Healthcare Partners LLC reduced stake in above stock

Sold off

Ticker	$ Sold
performant healthcare inc	-4,857,090
replimune group inc	-8,330,440
ardelyx inc	-1,180,260
nurix therapeutics inc	-2,600,010
verona pharma plc	-18,717,200
merus n v	-8,572,750
revvity inc	-15,204,000
atyr pharma inc	-760,500

Parkman Healthcare Partners LLC got rid off the above stocks

Sector Distribution

Parkman Healthcare Partners LLC has about 85.3% of it's holdings in Healthcare sector.

Sector	%
Healthcare	85.3
Others	14.2

Market Cap. Distribution

Parkman Healthcare Partners LLC has about 39.4% of it's portfolio invested in the large-cap and mega-cap stocks.

Category	%
LARGE-CAP	39.4
SMALL-CAP	27.6
UNALLOCATED	14.2
MID-CAP	12.4
MICRO-CAP	4.8

Stocks belong to which Index?

About 66.2% of the stocks held by Parkman Healthcare Partners LLC either belong to S&P 500 or RUSSELL 2000 index.

Index	%
RUSSELL 2000	36
Others	33.8
S&P 500	30.2

Top 5 Winners (%)		%
QURE	uniqure nv	283.5 %
	mineralys therapeutics inc	178.7 %
AMLX	amylyx pharmaceuticals inc	105.9 %
PGEN	precigen inc	97.2 %
TERN	terns pharmaceuticals inc	89.3 %

Top 5 Winners ($)		$
QURE	uniqure nv	17.5 M
ALNY	alnylam pharmaceuticals inc	11.7 M
	mineralys therapeutics inc	11.2 M
VRDN	viridian therapeutics inc	9.3 M
XERS	xeris biopharma holdings inc	6.8 M

Top 5 Losers (%)		%
LUNG	pulmonx corp	-34.2 %
RXST	rxsight inc	-24.7 %
OM	outset med inc	-24.2 %
SIBN	si-bone inc	-21.4 %
DXCM	dexcom inc	-20.2 %

Top 5 Losers ($)		$
DXCM	dexcom inc	-4.0 M
BSX	boston scientific corp	-3.5 M
OM	outset med inc	-2.6 M
RXST	rxsight inc	-2.0 M
	qiagen nv	-1.7 M

Parkman Healthcare Partners LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Parkman Healthcare Partners LLC

Parkman Healthcare Partners LLC has 90 stocks in it's portfolio. About 30.3% of the portfolio is in top 10 stocks. DXCM proved to be the most loss making stock for the portfolio. QURE was the most profitable stock for Parkman Healthcare Partners LLC last quarter.

Last Reported on: 14 Nov, 2025

Ticker	Namesorted ascending	% Portfolio	Shares Held	$ Value	Type	% Change
ACLX	arcellx inc	1.28	149,848	12,302,500	reduced	-14.02

AGIO	agios pharmaceuticals inc	0.42	100,380	4,029,250	new

AGLE	spyre therapeutics inc	0.35	200,753	3,364,620	new

ALNY	alnylam pharmaceuticals inc	4.17	87,690	39,986,600	reduced	-5.03

AMLX	amylyx pharmaceuticals inc	0.82	579,174	7,870,980	reduced	-10.9

ANIP	ani pharmaceuticals inc	0.00	0.00	0.00	sold off	-100

ANNX	annexon inc	0.13	405,953	1,238,160	added	0.44

AORT	artivion inc	0.98	221,044	9,359,000	added	14.71

ARDX	ardelyx inc	0.00	0.00	0.00	sold off	-100

ASMB	assembly biosciences inc	0.67	250,981	6,425,110	new

ATEC	alphatec hldgs inc	1.06	696,980	10,134,100	added	7.41

AXGN	axogen inc	0.93	501,832	8,952,680	reduced	-25.61

BCRX	biocryst pharmaceuticals inc	0.80	1,012,660	7,686,120	added	0.46

BFLY	butterfly network inc	0.12	602,192	1,162,230	new

BIIB	biogen inc	1.90	130,165	18,233,500	new

BMRN	biomarin pharmaceutical inc	0.71	125,949	6,821,400	reduced	-44.06

BSX	boston scientific corp	4.42	434,377	42,408,200	added	53.4

CARA	tvardi therapeutics inc	0.26	65,000	2,533,050	new

CERT	certara inc	0.70	551,850	6,743,610	added	10.37

CMPS	compass pathways plc	0.06	100,000	573,000	new